• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

心脏X综合征的治疗进展:针对潜在病理生理学的必要性。

Therapeutic development in cardiac syndrome X: a need to target the underlying pathophysiology.

作者信息

Lim Tiong K, Choy AnnaMaria J, Khan Faisel, Belch Jill J F, Struthers Allan D, Lang Chim C

机构信息

Division of Medicine and Therapeutics, University of Dundee, Dundee, UK.

出版信息

Cardiovasc Ther. 2009 Spring;27(1):49-58. doi: 10.1111/j.1755-5922.2008.00070.x.

DOI:10.1111/j.1755-5922.2008.00070.x
PMID:19207480
Abstract

Morbidity of patients with cardiac syndrome X (typical anginal-like chest pain and normal coronary arteriogram) is high with continuing episodes of chest pain and frequent hospital readmissions. Management of this syndrome represents a major challenge for the treating physician. Conventional therapies with antianginal agents such as nitrates, calcium channel antagonists, classic beta-adrenoceptor blockers and nicorandil have been tried, with variable success. However, this might be related to a failure to target the underlying pathophysiology and, clearly, more effective therapies are needed. Supporting evidence for the important role of endothelial dysfunction and oxidative stress in the pathogenesis of cardiac syndrome X has come from the recent observation that basal superoxide production predicts future cardiovascular events in this patient group. This review will discuss the pathophysiology, current medical management and potential new pharmacological treatment for patients with cardiac syndrome X which target endothelial dysfunction and oxidative stress. What's already known about this topic? Morbidity of patients with cardiac syndrome X is high. The important role of endothelial dysfunction and oxidative stress in the pathogenesis of cardiac syndrome X. What does this article add? This review will discuss the pathophysiology, current medical management and potential new pharmacological treatment for patients with cardiac syndrome X which target endothelial dysfunction and oxidative stress.

摘要

心脏X综合征(典型的心绞痛样胸痛且冠状动脉造影正常)患者的发病率较高,胸痛持续发作且频繁住院。对该综合征的管理对治疗医生来说是一项重大挑战。已经尝试了使用抗心绞痛药物如硝酸盐、钙通道拮抗剂、经典β肾上腺素能受体阻滞剂和尼可地尔进行常规治疗,但效果不一。然而,这可能与未能针对潜在的病理生理学有关,显然,需要更有效的治疗方法。内皮功能障碍和氧化应激在心脏X综合征发病机制中的重要作用的支持证据来自最近的观察结果,即基础超氧化物生成可预测该患者群体未来的心血管事件。本综述将讨论针对内皮功能障碍和氧化应激的心脏X综合征患者的病理生理学、当前医学管理及潜在的新药治疗。关于这个主题已知的内容有哪些?心脏X综合征患者的发病率较高。内皮功能障碍和氧化应激在心脏X综合征发病机制中的重要作用。本文补充了什么内容?本综述将讨论针对内皮功能障碍和氧化应激的心脏X综合征患者的病理生理学、当前医学管理及潜在的新药治疗。

相似文献

1
Therapeutic development in cardiac syndrome X: a need to target the underlying pathophysiology.心脏X综合征的治疗进展:针对潜在病理生理学的必要性。
Cardiovasc Ther. 2009 Spring;27(1):49-58. doi: 10.1111/j.1755-5922.2008.00070.x.
2
Cardiac syndrome X and endothelial dysfunction: new concepts in prognosis and treatment.心脏X综合征与内皮功能障碍:预后与治疗的新概念
Am J Med. 2006 Jul;119(7):560-6. doi: 10.1016/j.amjmed.2005.07.009.
3
Selective estrogen receptor modulators promising for cardiac syndrome X.选择性雌激素受体调节剂有望用于治疗心脏X综合征。
J Postgrad Med. 2010 Oct-Dec;56(4):328-31. doi: 10.4103/0022-3859.70936.
4
Does reversal of oxidative stress and inflammation provide vascular protection?氧化应激和炎症的逆转是否能提供血管保护作用?
Cardiovasc Res. 2009 Mar 1;81(4):649-59. doi: 10.1093/cvr/cvn354. Epub 2008 Dec 20.
5
Cardiac syndrome X.心脏X综合征
Int J Clin Pract. 2005 Sep;59(9):1063-9. doi: 10.1111/j.1742-1241.2005.00593.x.
6
Role of endothelial dysfunction and insulin resistance in angina pectoris and normal coronary angiogram.内皮功能障碍和胰岛素抵抗在心绞痛及冠状动脉造影正常中的作用。
Herz. 2005 Feb;30(1):48-54. doi: 10.1007/s00059-005-2638-0.
7
Endothelial dysfunction: clinical strategies for treating oxidant stress.内皮功能障碍:治疗氧化应激的临床策略
Am Heart J. 2003 Aug;146(2):218-26. doi: 10.1016/S0002-8703(02)94796-4.
8
Inflammation: a possible pathogenic link to cardiac syndrome X.炎症:与心脏X综合征可能的致病联系。
Med Hypotheses. 2006;66(1):87-91. doi: 10.1016/j.mehy.2005.08.005. Epub 2005 Sep 21.
9
Endothelial dysfunction in metabolic syndrome: prevalence, pathogenesis and management.代谢综合征中的内皮功能障碍:流行情况、发病机制与管理。
Nutr Metab Cardiovasc Dis. 2010 Feb;20(2):140-6. doi: 10.1016/j.numecd.2009.08.006. Epub 2009 Oct 14.
10
Cardiac syndrome X: current concepts.心脏 X 综合征:当前概念。
Int J Cardiol. 2010 Jul 9;142(2):113-9. doi: 10.1016/j.ijcard.2009.11.021. Epub 2010 Feb 7.

引用本文的文献

1
Small-vessel disease in the brain.脑部小血管疾病
Am Heart J Plus. 2023 Feb 18;27:100277. doi: 10.1016/j.ahjo.2023.100277. eCollection 2023 Mar.
2
Myocardial Microvascular Physiology in Acute and Chronic Coronary Syndromes, Aortic Stenosis, and Heart Failure.急性和慢性冠状动脉综合征、主动脉瓣狭窄及心力衰竭中的心肌微血管生理学
J Interv Cardiol. 2022 Jan 26;2022:9846391. doi: 10.1155/2022/9846391. eCollection 2022.
3
Prognostic value of structural and functional coronary microvascular dysfunction in patients with non-obstructive coronary artery disease; from the multicentre international ILIAS registry.
结构性和功能性冠状动脉微血管功能障碍对非阻塞性冠状动脉疾病患者的预后价值;来自多中心国际 ILIAS 登记研究。
EuroIntervention. 2022 Oct 21;18(9):719-728. doi: 10.4244/EIJ-D-22-00043.
4
Why names matter for women: MINOCA/INOCA (myocardial infarction/ischemia and no obstructive coronary artery disease).为何名称对女性至关重要:MINOCA/INOCA(心肌梗死/缺血且无阻塞性冠状动脉疾病)
Clin Cardiol. 2018 Feb;41(2):185-193. doi: 10.1002/clc.22894. Epub 2018 Mar 2.
5
Ischemia and No Obstructive Coronary Artery Disease (INOCA): Developing Evidence-Based Therapies and Research Agenda for the Next Decade.缺血与无阻塞性冠状动脉疾病(INOCA):为未来十年制定循证疗法与研究议程
Circulation. 2017 Mar 14;135(11):1075-1092. doi: 10.1161/CIRCULATIONAHA.116.024534.
6
Coronary Microvascular Dysfunction - Epidemiology, Pathogenesis, Prognosis, Diagnosis, Risk Factors and Therapy.冠状动脉微血管功能障碍——流行病学、发病机制、预后、诊断、危险因素及治疗
Circ J. 2016 Dec 22;81(1):3-11. doi: 10.1253/circj.CJ-16-1002. Epub 2016 Nov 29.
7
Value of Chromosome 9p21 Polymorphism for Prediction of Cardiovascular Mortality in Han Chinese Without Coronary Lesions: An Observational Study.9号染色体p21多态性对无冠状动脉病变的汉族人群心血管死亡率预测的价值:一项观察性研究。
Medicine (Baltimore). 2015 Sep;94(39):e1538. doi: 10.1097/MD.0000000000001538.
8
Cardiac Syndrome X: update 2014.心脏X综合征:2014年更新
Cardiol Clin. 2014 Aug;32(3):463-78. doi: 10.1016/j.ccl.2014.04.006. Epub 2014 Jun 2.
9
Coronary microvascular dysfunction: an update.冠状动脉微血管功能障碍:最新进展
Eur Heart J. 2014 May;35(17):1101-11. doi: 10.1093/eurheartj/eht513. Epub 2013 Dec 23.
10
Assessment of endothelial function by brachial artery flow mediated dilatation in microvascular disease.通过肱动脉血流介导的扩张评估微血管疾病中的内皮功能。
Cardiovasc Ultrasound. 2011 Dec 9;9:40. doi: 10.1186/1476-7120-9-40.